Karl E. Rickels
#84,518
Most Influential Person Now
Karl E. Rickels's AcademicInfluence.com Rankings
Karl E. Rickelsphilosophy Degrees
Philosophy
#3013
World Rank
#4965
Historical Rank
Logic
#910
World Rank
#1480
Historical Rank
Download Badge
Philosophy Biology
Karl E. Rickels's Degrees
- Doctorate Medicine University of Pennsylvania
Why Is Karl E. Rickels Influential?
(Suggest an Edit or Addition)Karl E. Rickels's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. (1974) (4317)
- The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale (1976) (2281)
- The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. (1974) (911)
- Short form of depression inventory: cross-validation. (1974) (778)
- Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. (2001) (474)
- Psychiatric illness in family practice. (1980) (461)
- Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. (1993) (419)
- A Comparison of Two Psychiatric Screening Tests (1976) (416)
- Symptoms of Emotional Distress in a Family Planning Service: Stability over a Four-Week Period (1984) (379)
- Buspirone and diazepam in anxiety: a controlled study. (1982) (310)
- Psychological evaluation and support in a program of in vitro fertilization and embryo transfer. (1985) (300)
- Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. (1990) (291)
- Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. (2005) (276)
- Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. (2001) (266)
- Long-term diazepam therapy and clinical outcome. (1983) (246)
- L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. (2012) (228)
- Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. (2000) (214)
- Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. (1986) (212)
- Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone. (1988) (206)
- Comparison of alprazolam, imipramine, and placebo in the treatment of depression. (1983) (184)
- Neurotic symptom dimensions. As perceived by psychiatrists and patients of various social classes. (1971) (182)
- Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. (1990) (181)
- A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. (1995) (180)
- Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. (1999) (178)
- Reliability and validity of a daily diary for premenstrual syndrome (1996) (175)
- Clinical Effects of the 5‐HT1A Partial Agonists in Depression: A Composite Analysis of Buspirone in the Treatment of Depression (1990) (175)
- Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. (2003) (174)
- Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. (1993) (170)
- Clinical overview of serotonin reuptake inhibitors. (1990) (168)
- Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease (2013) (158)
- Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. (1983) (158)
- Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. (1980) (154)
- Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management (1998) (154)
- Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. (1975) (150)
- Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. (1994) (138)
- Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial. (2009) (137)
- Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. (1985) (135)
- A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. (1998) (133)
- Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible‐dose, progressive‐titration, placebo‐controlled trial (2008) (129)
- Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome. (1991) (125)
- Clinical Uses of Benzodiazepines (1993) (124)
- Nefazodone and Imipramine in Major Depression: A Placebo-Controlled Trial (1994) (121)
- Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress (2001) (120)
- Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. (2012) (117)
- Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. (1993) (116)
- Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder (2001) (113)
- Diphenhydramine in Insomniac Family Practice Patients: A Double‐Blind Study (1983) (113)
- What constitutes an adequate antidepressant trial for fluoxetine? (1990) (112)
- Dimensions of outpatient neurotic pathology: comparison of a clinical vrsus an empirical assessment. (1970) (105)
- Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. (1986) (100)
- A placebo-controlled study of effects of oral progesterone on performance and mood. (1992) (97)
- Factorial invariance of symptom dimensions in anxious and depressive neuroses. (1972) (97)
- The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. (2005) (95)
- Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. (1987) (94)
- Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. (1993) (93)
- Non-specific factors in drug therapy (1968) (92)
- Allopregnanolone Levels and Symptom Improvement in Severe Premenstrual Syndrome (2002) (91)
- Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial. (2006) (91)
- A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder (2004) (90)
- Chronic use of benzodiazepines and psychomotor and cognitive test performance (2004) (89)
- Symptom Profile of Major Depressive Disorder in Women with Eating Disorders (2007) (86)
- Benzodiazepine dependence and withdrawal in elderly patients. (1989) (86)
- Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. (1997) (86)
- BUSPIRONE IN TREATMENT OF PREMENSTRUAL SYNDROME (1989) (86)
- Emotional and Psychosocial Factors in Follow‐Up of Women After Ivf‐Et Treatment: A pilot investigation (1987) (85)
- A neuroendocrine test battery in bipolar patients and healthy subjects. (1983) (84)
- Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies. (1992) (82)
- Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. (2004) (82)
- Open trial of buspirone in the treatment of major depressive disorder. (1986) (82)
- Buspirone in major depression: a controlled study. (1991) (81)
- Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients. (1986) (80)
- The Hopkins Symptom Checklist. Assessing emotional distress in obstetric-gynecologic practice. (1976) (76)
- The Clinical Course and Long‐Term Management of Generalized Anxiety Disorder (1990) (76)
- Failure of buspirone to manage benzodiazepine withdrawal. (1986) (75)
- Gepirone in Anxiety: A Pilot Study (1987) (75)
- Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy. (2000) (75)
- Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. (1986) (75)
- Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. (1990) (74)
- Long-term benzodiazepine users 3 years after participation in a discontinuation program. (1991) (73)
- Panic disorder: long-term pharmacotherapy and discontinuation. (1998) (72)
- Pharmacological treatment for generalized anxiety disorder in adults: an update (2015) (71)
- Assessment of dosage deviation in outpatient drug research. (1970) (70)
- Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database. (2006) (70)
- Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome (1999) (69)
- The Clinical Inadequacy of the Placebo Model and the Development of an Alternative Conceptual Framework (2017) (69)
- Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. (2010) (69)
- SENSITIVITY OF SYMPTOM AND NONSYMPTOM-FOCUSED CRITERIA OF OUTPATIENT DRUG EFFICACY (1965) (67)
- Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms (1995) (67)
- A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. (2011) (67)
- Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. (1999) (66)
- The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial (2001) (66)
- Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. (2006) (66)
- Maintenance therapy with amitriptyline: a controlled trial. (1980) (65)
- Placebo response in generalized anxiety: its effect on the outcome of clinical trials. (1997) (64)
- Pharmacotherapy of generalized anxiety disorder. (2002) (64)
- Behavioral and emotional factors: comparisons of anovulatory infertile women with fertile and other infertile women. (1983) (64)
- Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. (1987) (64)
- Replication Of Symptom Distress Factors In Anxious Neurotic Outpatients. (1968) (63)
- Open trial of gepirone in the treatment of major depressive disorder (1987) (63)
- Personality Factors in Women With Premenstrual Syndrome (1995) (63)
- Ineffectiveness of progesterone suppository treatment for premenstrual syndrome (1991) (62)
- Characteristics of placebo responses in medical treatment of premenstrual syndrome. (1999) (62)
- Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial. (1997) (59)
- Concerns about clinical drug trials. (2000) (59)
- Core symptoms that discriminate premenstrual syndrome. (2011) (58)
- Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy (2004) (58)
- Overview and clinical presentation of generalized anxiety disorder. (2001) (57)
- PREVIOUS MEDICATION, DURATION OF ILLNESS AND PLACEBO RESPONSE (1966) (57)
- A placebo‐controlled, double‐blind, clinical trial of paroxetine in depressed outpatients (1989) (56)
- Buspirone in clinical practice. (1990) (56)
- Evaluating clinical improvement in anxious outpatients: a comparison of normal and treated neurotic patients. (1972) (56)
- Benzodiazepine dependence: management of discontinuation. (1990) (55)
- The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients (1998) (55)
- Lorazepam vs. alprazolam in the treatment of panic disorder. (1990) (55)
- Pharmacological treatment of generalized anxiety disorder (2011) (55)
- Adolescent contraceptive use: comparisons of male and female attitudes and information. (1980) (55)
- Long-term benzodiazepine therapy: benefits and risks. (1984) (54)
- Pharmacologic strategies for discontinuing benzodiazepine treatment. (1999) (54)
- Neurotics Who Fail to Take their Drugs (1965) (53)
- A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder. (2000) (52)
- The clinical presentation of generalized anxiety in primary-care settings: practical concepts of classification and management. (1997) (52)
- A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. (1993) (52)
- Nefazodone in the treatment of premenstrual syndrome: a preliminary study. (1994) (51)
- The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder. (1992) (51)
- PREDICTORS OF RESPONSE TO AMITRIPTYLINE AND PLACEBO IN THREE OUTPATIENT TREATMENT SETTINGS (1973) (50)
- Clorazepate and lorazepam: clinical improvement and rebound anxiety. (1988) (50)
- Emotional Distress Patterns Among Women Having First or Repeat Abortions (1980) (50)
- Are benzodiazepines overused and abused? (1981) (50)
- Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness: A Double-Blind, Placebo-Controlled Study (2007) (49)
- Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. (1999) (49)
- Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment (2012) (49)
- A controlled clinical trial of alprazolam for the treatment of anxiety. (1983) (49)
- Social class and race as mediator variables in neurotic symptomatology. (1971) (48)
- Paroxetine versus placebo: a double-blind comparison in depressed patients. (1992) (48)
- A comparison of paroxetine and placebo in depressed outpatients (1993) (48)
- Buspirone and imipramine for the treatment of major depression in the elderly. (1998) (47)
- Physician Withdrawal Checklist (PWC-20) (2008) (47)
- Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review (2018) (47)
- Dimensions of symptom distress in anxious neurotic outpatients. (1969) (47)
- Behavioral and emotional factors and treatment responses in a study of anovulatory infertile women. (1985) (46)
- Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder (2011) (45)
- Assessment of psychiatric illness severity by family physicians (1978) (45)
- Evaluating Premenstrual Symptoms in Medical Practice (1985) (45)
- Strategies for treatment of generalized anxiety in the primary care setting. (1997) (44)
- Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release. (2010) (44)
- Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial. (1996) (43)
- Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents. (1993) (43)
- A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety. (1989) (42)
- Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. (1993) (41)
- Combined medication and cognitive therapy for generalized anxiety disorder. (2011) (41)
- The Dexamethasone Suppression Test in Generalised Anxiety Disorder (1986) (40)
- Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder (2012) (39)
- An open-label trial of nefazodone in high comorbidity panic disorder. (1996) (38)
- Fluoxetine in major depression: a controlled study (1986) (37)
- Drug treatment in depression. Antidepressant or tranquilizer? (1967) (37)
- Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. (2000) (37)
- Early Childbearing: Perspectives of Black Adolescents on Pregnancy, Abortion and Contraception (1993) (37)
- Amitriptyline in anxious-depressed outpatients: a controlled study. (1974) (37)
- Comparison of two dosage regimens of fluoxetine in major depression. (1985) (36)
- Drug- and placebo-treated neurotic outpatients. Pretreatment levels of manifest anxiety, clinical improvement, and side reactions. (1967) (36)
- A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder (2008) (36)
- Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline. (2009) (35)
- The behavioral effects of benzodiazepines following long-term use. (1986) (35)
- The treatment of generalized anxiety disorder in patients with depressive symptomatology. (1993) (35)
- One-year follow-up of anxious patients treated with diazepam. (1986) (35)
- Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. (2005) (35)
- Medication discontinuation in panic disorder. (1992) (35)
- Chlordiazepoxide and hostility in anxious outpatients. (1974) (35)
- Effects of Medical History Factors on Symptom Severity in Women Meeting Criteria for Premenstrual Syndrome (1988) (34)
- Amitriptyline and trimipramine in neurotic depressed outpatients: a collaborative study. (1970) (33)
- Evaluating a household survey measure of psychic distress (1983) (33)
- Differential drug effects in neurotic depression. (1970) (33)
- Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study. (1993) (33)
- PREDICTORS OF AMITRIPTYLINE RESPONSE IN OUTPATIENT DEPRESSIVES (1972) (33)
- EVALUATION OF TRANQUILIZING DRUGS IN MEDICAL OUTPATIENTS: MEPROBAMATE, PROCHLORPERAZINE, AMOBARBITAL SODIUM, AND PLACEBO (1959) (33)
- Fluoxetine in the treatment of premenstrual syndrome (1990) (33)
- Growth hormone, prolactin and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers (1982) (32)
- Psychomotor performance following the long-term use of benzodiazepines. (1985) (32)
- DIFFERENT POPULATIONS, DIFFERENT DRUG RESPONSES A COMPARATIVE STUDY OF TWO ANTI‐DEPRESSANTS, EACH USED IN TWO DIFFERENT PATIENT GROUPS (1964) (32)
- Ziprasidone Treatment of Refractory Generalized Anxiety Disorder: A Placebo-Controlled, Double-Blind Study (2010) (32)
- Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome (1995) (32)
- Clinical Subtypes of Premenstrual Syndrome and Responses to Sertraline Treatment (2011) (31)
- Fluvoxamine for premenstrual dysphoric disorder: a pilot study. (1996) (31)
- Buspirone in the treatment of panic disorder: a controlled pilot comparison with clorazepate. (1988) (30)
- Iprindole and Imipramine in Non-Psychotic Depressed Out-Patients (1973) (30)
- Benzodiazepines for treatment of panic attacks: a new look. (1986) (30)
- Never-pregnant adolescents and family planning programs: contraception, continuation, and pregnancy risk. (1982) (30)
- Social factors and neurotic symptoms in family practice. (1975) (29)
- A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. (1997) (28)
- Side reactions in neurotics. I. A comparison of two methods of assessment. (1970) (28)
- Triazolam in insomniac family practice patients (1975) (28)
- Benzodiazepines in the treatment of anxiety. (1982) (28)
- Hopkins Symptom Checklist (2013) (27)
- Paradoxical influence of a therapeutic side-effect interpretation. (1966) (27)
- Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder (2004) (27)
- Iprindole in neurotic depressed general practice patients: a controlled study. (1968) (26)
- The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. (1992) (26)
- International Task Force on Benzodiazepines (2018) (26)
- Methodology of the Evaluation of Psychotropic Drugs (1990) (26)
- PHARMACOTHERAPY IN NEUROTIC DEPRESSION: DIFFERENTIAL POPULATION RESPONSES (1967) (26)
- Early treatment response in anxious outpatients treated with diazepam (1985) (26)
- Relapse after short-term drug therapy in neurotic outpatients. (1980) (26)
- The spectrum of generalised anxiety in clinical practice: the role of short-term, intermittent treatment∗ (1998) (25)
- Buspirone in depressed outpatients: a controlled study. (1990) (25)
- Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder (2012) (25)
- Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response. (1985) (25)
- Dr. Schweizer and Associates Reply (1989) (25)
- Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder: Results of a Randomized Trial (2010) (24)
- Drug treatment in depressive illness. (1970) (24)
- Withdrawal and pseudowithdrawal from diazepam therapy. (1981) (24)
- Drug use in outpatient treatment. (1968) (24)
- Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder (2017) (23)
- Amoxapine and imipramine in the treatment of depressed outpatients: a controlled study. (1981) (23)
- Fenfluramine in the treatment of obesity. (1973) (23)
- What is generalized anxiety disorder? (2001) (23)
- Antianxiety Drugs: Clinical use in Psychiatry (1978) (23)
- PSYCHOPHARMACOLOGIC AGENTS: A CLINICAL PSYCHIATRIST'S INDIVIDUALISTIC POINT OF VIEW PATIENT AND DOCTOR VARIABLES (1963) (23)
- Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depression. (2009) (22)
- Insulin-induced hypoglycemia and panic attacks. (1986) (22)
- Early response and 8‐week treatment outcome in GAD (2006) (22)
- Nefazodone: aspects of efficacy. (1995) (22)
- Benzodiazepine dependence, withdrawal severity, and clinical outcome: effects of personality. (1988) (22)
- A Comparison of Doctor and Patient Improvement Ratings in a Drug (Meprobamate) Trial (1965) (22)
- Drug effects and initial severity of symptomatology (1965) (22)
- Should Benzodiazepines Be Replaced by Antidepressants in the Treatment of Anxiety Disorders? Fact or Fiction? (2013) (21)
- Generalized anxiety disorder : symptomatology, pathogenesis and management (2002) (21)
- Some comments on non-drug factors in psychiatric drug therapy. (1965) (21)
- Trazodone in depressed outpatients. (1982) (21)
- Target symptoms: a promising improvement criterion in psychiatric drug research. (1968) (21)
- AMITRIPTYLINE, DIAZEPAM, AND PHENOBARBITAL SODIUM IN DEPRESSED OUTPATIENTS (1973) (21)
- Extent of agreement between patient and physician ratings of emotional distress. (1982) (21)
- Adolescent health services and contraceptive use. (1978) (21)
- An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant. (1988) (21)
- The effects of psychotherapy upon measured anxiety and regression. (1966) (20)
- Zalospirone in major depression: a placebo-controlled multicenter study. (1996) (20)
- Hydroxyzine and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study. (1970) (20)
- Use of antianxiety agents in anxious outpatients (1978) (20)
- Use of placebo in clinical trials. (1986) (20)
- DOSAGE DEVIATION AND DRUG EFFECTS IN DRUG TRIALS (1965) (20)
- Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder: Results of a Double-Blind, Placebo-Controlled Trial (2008) (19)
- Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability. (1998) (19)
- Prazepam in anxiety: a controlled clinical trial. (1977) (19)
- Clinical trials of hypnotics. (1983) (19)
- Multicenter controlled study of oxazepam in anxious elderly outpatients. (1982) (19)
- Effects of psychotropic agents on primary depression (1981) (19)
- Tybamate--a perplexing drug. (1968) (19)
- A DOUBLE-BLIND EVALUATION OF TYBAMATE IN ANXIOUS NEUROTIC MEDICAL CLINIC PATIENTS. (1964) (19)
- Urban black adolescents who obtain contraceptive services before or after their first pregnancy. Psychosocial factors and contraceptive use. (1984) (19)
- Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder (2011) (19)
- Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder (2013) (19)
- A clinical study of lactation suppression. (1973) (18)
- A Measure of Emotional Distress in Private Gynecologic Practice (1971) (18)
- Why do clinical trials fail? (2007) (18)
- A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression. (1986) (18)
- A COMPARATIVE CONTROLLED CLINICAL TRIAL OF SEVEN HYPNOTIC AGENTS IN MEDICAL AND PSYCHIATRIC IN‐PATIENTS (1963) (18)
- Psychotropic drug prescription in family practice. (1976) (17)
- The effect of anxiolytic drugs on memory in anxious subjects. (1988) (17)
- Doxepin and diazepam in general practice and hospital clinic neurotic patients: A collaborative controlled study (2004) (17)
- The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach. (2018) (17)
- The long-term management of generalized anxiety disorder: issues and dilemmas. (1996) (17)
- Imipramine and Buspirone in Patients With Panic Disorder Who Are Discontinuing Long-term Benzodiazepine Therapy (2003) (17)
- DOCTOR MEDICATION GUESSES: AN INDICATOR OF CLINICAL IMPROVEMENT IN DOUBLE-BLIND STUDIES. A CONTRIBUTION TO THE METHODOLOGY OF PSYCHIATRIC DRUG EVALUATION. (1965) (16)
- Treatment of Neurotic Depression with a New Antidepressant (1981) (16)
- [Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography]. (1994) (16)
- CONTROLLED PSYCHOPHARMACOLOGICAL RESEARCH IN GENERAL PRACTICE. (1964) (16)
- Need for a realistic appraisal of benzodiazepines (2015) (16)
- Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine (1977) (16)
- Nonbenzodiazepine anxiolytics: clinical usefulness. (1983) (16)
- Maprotiline (Ludiomil) and Imipramine in Depressed In-Patients: A Controlled Study (1975) (16)
- Side reactions in neurotics: II. Can patients judge which symptoms are caused by their medication? (1970) (16)
- SOME FACTORS INFLUENCING THE TREATMENT EXPECTATIONS OF ANXIOUS NEUROTIC OUTPATIENTS (1967) (15)
- Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder (2013) (15)
- THE USE OF PSYCHOTHERAPY WITH DRUGS IN THE TREATMENT OF ANXIETY. (1964) (15)
- Association analysis between the 5-HTTLPR polymorphism in the SLC6A4 gene and generalized anxiety disorder. (2011) (15)
- Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study. (1991) (15)
- The clinical use of hypnotics: indications for use and the need for a variety of hypnotics (1986) (14)
- Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes. (2001) (14)
- Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin (1983) (14)
- Meprobamate-benactyzine (Deprol) and placebo in two depressed outpatient populations. (1969) (14)
- Doxylamine succinate in insomniac family practice patients: a double-blind study (1984) (14)
- Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers (2004) (13)
- Over-the-counter daytime sedatives. A controlled study. (1973) (13)
- Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety (2018) (13)
- The self-rating depression scale (SDS) as a measure of psychotropic drug response. (1973) (13)
- Amitriptyline once daily vs three times daily in depressed outpatients. (1980) (13)
- DIAGNOSTIC POWER OF IPAT OBJECTIVE ANXIETY NEUROTICISM TESTS. (1964) (13)
- Psychotropic drug use in family practice. (1976) (13)
- The long-term management of generalized anxiety disorder : Issues and dilemmas. Discussion (1996) (13)
- THE CLINICAL FACTOR VALIDITY AND TRUENESS OF THE IPAT VERBAL AND OBJECTIVE BATTERIES FOR ANXIETY AND REGRESSION. (1965) (13)
- Medication discontinuation in panic disorder. Discussion (1993) (13)
- Maintenance treatment studies in anxiety disorders: some methodological notes. (1995) (12)
- Combined medication and CBT for generalized anxiety disorder with African American participants: reliability and validity of assessments and preliminary outcomes. (2014) (12)
- Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia. (2018) (12)
- The physician questionnaire: A useful tool in psychiatric drug research (2004) (12)
- Serum progesterone levels following vaginal administration of progesterone during the luteal phase. (1987) (12)
- The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressed (2020) (12)
- Coffee consumption, cigarette smoking and reporting of drowsiness in anxious patients treated with benzodiazepines or placebo (1981) (12)
- Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect? (1985) (12)
- Perphenazine-amitriptyline in neurotic depressed outpatients: a controlled collaborative study. (1970) (12)
- Adolescent contraceptive use: current status of practice and research. (1979) (12)
- Self-reports of emotional distress in a sample of urban black high school students (1982) (12)
- A double-blind evaluation of fenfluramine in anxious somatizing neurotic medical clinic patients. (1966) (11)
- Compliance and improvement in drug-treated and placebo-treated neurotic outpatients. (1966) (11)
- Paroxetine in the treatment of generalised anxiety disorder (2004) (11)
- Lofepramine and imipramine in unipolar depressed outpatients (1982) (11)
- Pills and improvement: A study of placebo response in psychoneurotic outpatients (2004) (11)
- Attrited and completed lower socioeconomic class clinic patients in psychiatric drug therapy. (1967) (11)
- Nomifensine, imipramine and placebo in depressed outpatients. (1982) (11)
- Evidence for the use of vilazodone in the treatment of major depressive disorder (2012) (11)
- Benzodiazepines in Anxiety Disorders. (2015) (11)
- Physician prognosis in relationship to drug and placebo response in anxious and depressed psychiatric outpatients. (1983) (11)
- Six-week trial with diazepam: some clinical observations. (1985) (11)
- Thiothixene and Thioridazine in Anxiety (1974) (11)
- Self-report of hostility and the incidence of side reactions in neurotic outpatients treated with tranquilizing drugs and placebo. (1967) (11)
- Diphenylhydantoin in neurotic anxiety. (1969) (11)
- Nonspecific factors and side effect complaints: FACTORS AFFECTING THE INCIDENCE OF DROWSINESS IN DRUG AND PLACEBO TREATED ANXIOUS AND DEPRESSED OUTPATIENTS (1979) (10)
- Benzodiazepines in emotional disorders. (1983) (10)
- Prior benzodiazepine exposure and benzodiazepine treatment outcome. (2000) (10)
- Ketazolam and Diazepam in Anxiety: A Controlled Study (1980) (10)
- Bromazepam and phenobarbital in anxiety: a controlled study. (1973) (10)
- Placebo‐controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder (1995) (10)
- ButcJbarbital sodium and chlordiazepoxide in anxious neulrotic outpatients: A collaborative conl'rolled study (1970) (10)
- Personality and Attitudinal Correlates of Response to Drug Treatment in Psychiatric Outpatients: 1. Theoretical Orientation and Measuring Instruments to be Employed (1962) (9)
- Alprazolam extended-release in panic disorder (2004) (9)
- Rapid onset of antidepressant activity with venlafaxine treatment (1995) (9)
- A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome. (2004) (9)
- A working model of clinical research in private practice. (1971) (8)
- PERSONALITY DIFFERENCES BETWEEN SOMATICALLY AND PSYCHOLOGICALLY ORIENTED NEUROTIC PATIENTS (1966) (8)
- Remission of Generalized Anxiety Disorder after 6 Months of Open-Label Treatment with Venlafaxine XR (2013) (8)
- Psychiatric residency training: changes over a decade. (1966) (8)
- Reply to Evidence for Short-Term Psychodynamic Psychotherapy for Depression (2012) (8)
- Pooling 12 nomifensine studies for efficacy generalizability. (1984) (8)
- Setting, patient, and doctor effects on drug response in neurotic patients (2004) (8)
- Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: A collaborative controlled study (2004) (8)
- PERSONALITY AND ATTITUDINAL CORRELATES OF RESPONSE TO DRUG TREATMENT IN PSYCHIATRIC OUTPATIENTS. III. NEUROTIC MEDICAL CLINIC PATIENTS OF LOWER SOCIOECONOMIC STATUS--A DEMOGRAPHIC STUDY. (1964) (8)
- Verbal ability (intelligence) and improvement in drug therapy of neurotic patients. (1965) (8)
- Personality and Attitudinal Correlates of Response to Drug Treatment in Psychiatric Outpatients: Ii. Preliminary Investigation and Implications for Further Research (1962) (8)
- Is a double-blind clinical trial really double-blind? (2004) (8)
- The dexamethasone suppression test as a predictor of antidepressant response (2004) (8)
- Drug response and important external events in the patient's life. (1965) (8)
- Metabolic Impairments Precede Changes in Hunger and Food Intake Following Short-Term Administration of Second-Generation Antipsychotics (2015) (8)
- CLYDE MOOD SCALE CHANGES IN ANXIOUS OUTPATIENTS PRODUCED BY CHLORDIAZEPOXIDE THERAPY (1967) (8)
- Clobazam and diazepam in anxiety (1981) (8)
- Haloperidol in anxiety. (1971) (8)
- The Differentiation Between Neurotic Depression and Anxiety and Drug Treatment (1979) (7)
- Brotizolam, a triazolothienodiazepine, in insomnia (1986) (7)
- Influence of maternal attitudes on urban, black teens' decisions about abortion v delivery. (1985) (7)
- Hostility conflict and the effect of chlordiazepoxide on change in hostility level. (1981) (7)
- Chlormezanone in anxiety: a drug rediscovered? (1974) (7)
- Group support in the treatment of PMS. (1986) (7)
- Predicting the relief of anxiety with meprobamate. An attempt at replication. (1972) (7)
- Medical and psychologic characteristics of women presenting with premenstrual symptoms. (1987) (7)
- Molindone and chlordiazepoxide in anxious neurotic outpatients. (1972) (7)
- A prospective study on the psychological effects of therapeutic abortion. (1974) (7)
- Hostility conflict in neurotic patients who prematurely terminate drug treatment. (1970) (7)
- Predicting the relief of anxiety with meprobamate. Nondrug factors in the response of psychoneurotic outpatients. (1968) (7)
- Assessment of Anxiety and Depression in Primary Care: Value of a Four-Item Questionnaire (2009) (7)
- The physician depression scale (PDS): a factor analytic study. (1973) (6)
- Withdrawal responses to abrupt discontinuation of desmethyldiazepam. (1984) (6)
- FACTORS INFLUENCING DOSAGE DEVIATION AND ATTRITION IN PLACEBO TREATED NEUROTIC OUTPATIENTS (1975) (6)
- Differential effects of chlordiazepoxide and fluphenazine in two anxious patient populations (2004) (6)
- Buspirone in the Treatment of Anxiety Disorders (2007) (6)
- Venlafaxine Extended-Release A Review of its Clinical Potential in the Management of Generalised Anxiety Disorder (2000) (6)
- Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses. (1970) (6)
- Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression (2000) (6)
- Buspirone and Gepirone (2009) (6)
- Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency (2019) (6)
- Long-term Therapeutic Use of Benzodiazepines (2016) (6)
- The combination of protriptyline and oxazepam in depressed neurotic general practice patients. (1971) (6)
- Combination of meprobamate and benactyzine (Deprol) and constituents in neurotic depressed outpatients. (1971) (6)
- Side reactions on meprobamate and placebo. (1967) (6)
- PMS treatment approaches and progesterone therapy. (1985) (6)
- Diazepam and halazepam in anxiety: some prognostic indicators. (1978) (6)
- Medication attitudes and drug response. (1969) (6)
- THE RELATIONSHIP OF CLINICAL SYMPTOMS AND IPATFACTORED TESTS OF ANXIETY, REGRESSION AND ASTHENIA: A FACTOR ANALYTIC STUDY (1968) (6)
- Pipradrol in Mild Depression: A Controlled Study (1974) (6)
- Diazepam and desmethyldiazepam plasma concentrations in chronic anxious outpatients. (1984) (6)
- The impact of favorable and unfavorable life events on psychotropic drug response (2004) (6)
- Course of premenstrual syndrome symptom severity after treatment. (1992) (6)
- A CLINICAL EVALUATION OF HYDROXYZINE AND PLACEBO IN ANXIOUS PSYCHIATRIC OUTPATIENTS. (1965) (6)
- Benzodiazepines: clinical use patterns. (1980) (6)
- Psychopharmacologic agents: prescription patterns of non-psychiatrists. (1977) (5)
- Self-Estimates in Anxious and Depressed Outpatients Treated with Pharmacotherapy (1978) (5)
- A placebo-controlled study of enciprazine in the treatment of generalized anxiety disorder: a preliminary report. (1990) (5)
- Recent advances in anxiolytic therapy. (1981) (5)
- Developments in psychopharmacology. (1966) (5)
- Post-coital contraception: medical and social factors of the morning after pill. (1977) (5)
- Medication, anxiety reduction and patient report of significant life situation events. (1971) (5)
- Efficacy and safety of venlafaxine for premenstrual dysphoric disorder (2001) (5)
- Short-Term Dynamic Therapy Vs. Pharmacotherapy For Major Depressive Disorder (2012) (5)
- HUMANISM IN CLINICAL RESEARCH. (1964) (5)
- A collaborative research model in family practice. (1974) (5)
- The drug treatment of anxiety and panic disorder (1988) (5)
- Dropout contact by mail: a useful research tool. (1968) (5)
- Antianxiety Agents (Benzodiazepines and Other Sedative Hypnotics; Beta-Blockers) (1987) (5)
- Medical, psychologic, and social factors in morning-after pill utilization. (1976) (5)
- Clomipramine and amitriptyline in depressed outpatients (1974) (5)
- Prediction of response to chlordiazepoxide and placebo in anxious outpatients: an attempt at replication. (1978) (5)
- Benzoctamine and chlordiazepoxide in anxious outpatients: a collaborative study. (1972) (4)
- Drug Combination Therapy in Neurotic Depression: Its Advantages and Disadvantages* (1971) (4)
- Drugs and the Autonomic Nervous System (1961) (4)
- Emotional distress in morning‐after pill patients (1979) (4)
- Double‐blind comparison of doxepin and desipramine in patients with primary affective disorder (1982) (4)
- Opioid Pharmacogenetics of Alcohol Addiction (2013) (4)
- Butabarbital sodium and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study. (1970) (4)
- Anxiety: New Treatment Perspectives (2002) (4)
- Anxiolytics: indications, benefits, and risks of short- and long-term benzodiazepine therapy: current research data. (1993) (4)
- Tricyclic plasma levels in depressed outpatients treated with amitriptyline (2004) (4)
- The low socio-economic psychiatric outpatient (patient reactions ot drug therapy). (1969) (4)
- Halazepam and diazepam in neurotic anxiety: A double-blind study (1977) (4)
- Q-SORT PATTERNS OF SELF-EVALUATION IN THREE NEUROTIC CLINIC POPULATIONS. (1965) (4)
- Antianxiety therapy: potential value of long-term treatment. (1987) (4)
- A study of the concordance between observer and patient rating scales [proceedings]. (1978) (4)
- TEMPORAL CHANGE IN HANDWRITING EXPANSIVENESS IN DEPRESSED AND SCHIZOPHRENIC INPATIENTS (1964) (4)
- Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study. (1982) (4)
- Setting, patient, and doctor effects on drug response in neurotic patients (2004) (3)
- Double-blind placebo-controlled study of cilobamine in major depression-lack of therapeutic efficacy (1986) (3)
- Controlled evaluation of several tranquilizing agents in anxious neurotic outpatients. (1963) (3)
- Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia. (1978) (3)
- The private practice research group: cooperative efforts in drug evaluation. (1969) (3)
- Hormonal changes in premenstrual syndrome. (1985) (3)
- Controlled psychopharmacological research in private psychiatric practice (2004) (3)
- Patient personality and demographic factors as predictors of early response to psychotropic drug treatment. (1970) (3)
- The hippuric acid index: application of the hippuric acid test as an index of human free anxiety. (1959) (3)
- Clinical management of benzodiazepine dependence. (1985) (3)
- Lofepramine and imipramine in unipolar depressed outpatients. A placebo controlled study. (1982) (3)
- Are neurotic patients in psychotropic drug trials representative? A comparison of study and non-study patients in four family practices. (1974) (3)
- Pharmacotherapy of Depression (A Questionnaire Survey of a Group of Psychiatrists and General Practitioners) (1962) (3)
- Achieving Remission in Generalized Anxiety Disorder (2009) (3)
- Entry and exit from treatment: some consequences of pretreatment experience for treatment response. (1973) (3)
- Validation of the MacAndrew-Rosen drug therapy scale. (1970) (3)
- Multicenter controlled study of oxazepam in anxious elderly outpatients (1982) (3)
- Discontinuation studies with alprazolam (1990) (3)
- Responders and nonresponders to chlordiazepoxide and placebo: a discriminant function analysis. (1980) (3)
- BENZODIAZEPINES: TOLERANCE AND WITHDRAWAL: THE CLINICIAN'S POINT OF VIEW (1992) (3)
- Meprobamate and phenobarbital sodium in anxious neurotic psychiatric and medical clinic outpatients (1964) (3)
- Desvenlafaxine succinate for the treatment of major depressive disorder (2008) (3)
- Differential reliability in rating psychopathology and global improvement (1970) (3)
- Chlorpromazine and placebo in anxious neurotic outpatients: A controlled study (1978) (2)
- Pre-treatment self estimates and clinical improvement with tranquilizer therapy. (1967) (2)
- Clinical studies of "specific" anxiolytics as therapeutic agents. (1987) (2)
- Drug evaluation in private practice. (1968) (2)
- Hostility Conflict and Reporting of Side Effects by Psychiatric Outpatients (1980) (2)
- Introduction. Anxiety: New Treatment Perspectives (2002) (2)
- A clinical evaluation of a new psycholeptic acridan compound, SKF-14336. (1967) (2)
- Clomacran in anxious neurotic outpatients: a controlled study. (1972) (2)
- Loxapine in geriatric patients with chronic brain syndrome (1984) (2)
- Lorazepam and diazepam in anxious outpatients. A controlled study. (1976) (2)
- Evaluating antidepressants and anxiolytics. (1990) (2)
- The controlled evaluation of imipramine and amitriptyline in hospitalized depressed psychiatric patients (1964) (2)
- Clinical pharmacology of benzodiazepines. (1985) (2)
- Clomacran and chlorpromazine in psychotic outpatients: a controlled study. (1971) (2)
- Desvenlafaxine succinate for the treatment of major depressive disorder. (2008) (2)
- Limbitrol (amitriptyline plus chlordiazepoxide) revisited. (1981) (2)
- Orthogonal factors vs. interdependent variables as predictors of drug treatment response in anxious outpatients (2004) (2)
- A placebo-controlled, double-blind, flexible dosage study to evaluate the efficacy and tolerability of sertraline in the treatment of DSM-IV generalized anxiety disorder (2002) (2)
- Consumer Advertising Can Be Misleading (2006) (2)
- NIALAMIDE AND PLACEBO IN DEPRESSED PSYCHIATRIC CLINIC PATIENTS. (A CONTROLLED DOUBLE BLIND STUDY). (1963) (2)
- Introduction/A New Concept in the Treatment of Anxiety (1997) (2)
- Lorazepam vs. alprazolam in the treatment of panic disorder. (1988) (2)
- Some Personality Correlates of Suggestibility in Normals and Neurotics (1964) (2)
- Oxazepam and Meprobamate in Anxious Neurotic Outpatients (1969) (1)
- Behavioral effects of alprazolam in chronic therapeutic users. (1989) (1)
- The Minnesota Multiphasic Personality Inventory in predicting response to pharmacotherapy of neurotic outpatients. (1979) (1)
- The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. (1991) (1)
- Antidepressant Trials: Are the Diminishing Effect Sizes of Efficacy Trials Avoidable? (2017) (1)
- Handwriting Size and Self-Reported Hostility in Drug-Treated Neurotic Outpatients: Comparison of Completers and Dropouts (1969) (1)
- Mesoridazine (TPS-23) in chronic neurotic clinic patients. (1968) (1)
- Possible nonlinear pharmacokinetics of desipramine after once daily dosing. (1986) (1)
- What is generalized anxiety disorder? Discussion (2001) (1)
- Doxepin versus imipramine in psychoneurotic depressed patients with sleep disturbance: a double-blind study. (1978) (1)
- Anti-anxiety drugs in neurotic outpatients. (1967) (1)
- Molindone in anxious neurotic psychiatric outpatients: a pilot study. (1970) (1)
- Clinical comparisons. (1980) (1)
- POST-COITAL CONTRACEPTION: MEDICAL AND SOCIAL FACTORS OF THE MORNING AFTER PILL (1977) (1)
- Pilot study of alpidem, a new nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder. (1988) (1)
- Prognostic indicators of 4-week clinical improvement with chlordiazepoxide and hydroxyzine in anxious neurotic outpatients. (1971) (1)
- A ONCE‐A‐DAY, SLOW‐RELEASE FORM OF ALPRAZOLAM FOR THE TREATMENT OF PANIC DISORDER: A PLACEBO‐CONTROLLED STUDY (1992) (1)
- The Role of Compliance in the Premature Termination of Neurotic Outpatients in Psychotropic Drug Treatments (1970) (1)
- Benzoctamine and Chlordiazepoxide in Anxiety: Some Predictors of Improvement (1973) (1)
- THE ROLE OF TRANQUILIZERS IN MEDICAL PRACTICE IN THE CONTROL OF ANXIETY. IMPORTANT AND RELEVANT ASPECTS OF TRANQUILIZER THERAPY. (1964) (1)
- Premenstrual Syndrome and Progesterone Suppositories-Reply (1991) (1)
- The impact of medical and social factors in teenage pregnancy. (1988) (1)
- The Course of Adverse Events in Venlafaxine XR Treatment in Generalized Anxiety Disorder (2019) (1)
- Short-term administration of the atypical antipsychotic olanzapine induces insulin resistance in healthy subjects, independent of weight gain or psychiatric disease (2010) (1)
- The beta-blocker atenolol in anxiety: a controlled study (1986) (1)
- 189 Central autonomie reactivity in humans. (it's alteration by motor activity, adrenaline, and cns depressing and tranquillizing agents, e.g. amobarbital sodium, nevental, meprobamate, carisoprodol.) (1961) (0)
- Older antidepressant drugs for generalized anxiety disorder: developing the concept (2000) (0)
- Editorial: Clinical evaluation of OTC agents. (1974) (0)
- S-26-4 Mood effects of hormonal interventions — Comparisons to conventional antidepressants (1996) (0)
- [The practice of A-subgroups determination for serial studies and transfusion purposes]. (1954) (0)
- High dosages of meprobamate in chronic schizophrenia. (1962) (0)
- SocialFactors and NeuroticSymptoms in Family Practice (1975) (0)
- Predicting relief from anxiety with phenobarbital. (1974) (0)
- Severe erythema multiforme associated with zimelidine: a case report (1985) (0)
- Research trends in human psychopharmacology. (1957) (0)
- VENLAFAXINE VS. IMIPRAMINE FOR THE TREATMENT OF DEPRESSION (1992) (0)
- Medication Guesses in Double-Blind Studies. Author's reply (2010) (0)
- THE ANXIOLYTIC AGENTS AND THEIR LIMITATIONS (1978) (0)
- Prazepam in anxiety: a controlled clinical trial [proceedings]. (1977) (0)
- Can Anticonvulsants Help Patients With Anxiety Disorders ? (2017) (0)
- Research activity by private practive psychiatrists. Collaborative studies in private practice [proceedings]. (1977) (0)
- IVtr ainten an c e Th enapy',r,'ith .A.naitniptylirne : .A' C o ratnolle d Trial (1979) (0)
- Phenaglycodol in anxiety: a controlled study. (1975) (0)
- Re: Over-the-Counter Drugs for the Treatment of Mood and Anxiety Disorders – The Views of German Pharmacists. By J. Hamann, K. Linde, H. D. Schweiger, O. Kusmakow, H. Foerstl, Pharmacopsychiatry 2014; 47: 84–88 (2014) (0)
- Symptom Distress Checklist-31 (2015) (0)
- PREMENSTRUAL SYNDROME AND PROGESTERONE SUPPOSITORIES. AUTHOR'S REPLY (1991) (0)
- A comparative evaluation of two hypnotic agents in genral practice patients with insomnia. (1972) (0)
- TYBAMATE IN TREATMENT RESISTANT HEADACHES (1971) (0)
- Addressing `Gray' Areas in Teenage Pregnancy Debate (1994) (0)
- Hopkins Symptom Checklist, Depression Items (HSCL) 1974 (1981) (0)
- NEFAZODONE TREATMENT FOR PREMENSTRUAL SYMPTOMS (1992) (0)
- Contents Vol. 82, 2013 (2013) (0)
- Corrigendum to “Combined Medication and CBT for Generalized Anxiety Disorder With African American Participants: Reliability and Validity of Assessments and Preliminary Outcomes” [Behavior Therapy 45 (2014) 495–506] (2015) (0)
- Use of reproductive health care services by minority women and their impact. (1984) (0)
- Treatment of benzodiazepine dependence (1987) (0)
- GENERAL PRACTICE PATIENTS IN CLINICAL RESEARCH: RELEVANT ISSUES (1981) (0)
- CLINICAL EVALUATION OF SU-10704 IN ANXIOUS PATIENTS. (1965) (0)
- Gepirone in Depression and Anxiety Disorders An Initial Appraisal of its Clinical Potential (1994) (0)
- CLINICAL EVALUATION OF OTC AGENTS (1974) (0)
- S-42-3 Are drug-placebo differences in the treatment ofanxiety disorders shrinking over the years? (1996) (0)
- Noradrenergic and antidepressants and treatment response (2000) (0)
- Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz. (2009) (0)
- Thiothixene and Thioridazine in Anxiety (1974) (0)
- Long-term Diazepam Therapy-Reply (1984) (0)
- [Agar-hole test for examination of bacterial sensitivity with special reference to mixed infections]. (1955) (0)
- The double-blind drug study as a teaching device. (1961) (0)
- Robert W Downing, 1931–2002 (2002) (0)
- Drugs in Outpatient Practice1 (1971) (0)
- Drug abuse : medical and criminal aspects (1972) (0)
- placebo-controlled trial Nefazodone and imipramine in major depression: a (2011) (0)
- Side reactions in neurotic patients treated with Bristol CM-6. (1969) (0)
- [The effects of vitamins on the growth of pathogenic germs]. (1954) (0)
- USE OF DIRECT OBSERVATION IN THE TEACHING AND LEARNING OF PSYCHOTHERAPY. (1965) (0)
- The uncontrolled case report: a double-edged sword. (1988) (0)
- The safety and efficacy of alprazolam, imipramine, and placebo in the treatment of depression (1983) (0)
- Proceedings: The role of race and socioeconomic class level. (1974) (0)
- [Psychiatric training in the United States]. (1958) (0)
- A Déjà Vu Phenomenon in Psychiatry (2013) (0)
- The clinical screening of psychopharmacotherapeutic agents: a consideration of methodology. (1961) (0)
- Deanol (paxanol) in anxiety. (A contribution to the methodology of cross-over studies). (1966) (0)
- S-47-5 Benzodiazepines and antidepressants in the treatment of generalized anxiety (1996) (0)
- Drs. Rickels and Downing Reply (2015) (0)
- Medication guesses in double-blind studies. (2010) (0)
- The use of high dosage Deprol in alcoholic and narcotic withdrawal. (1962) (0)
- Neurotic, anxious, and depressed outpatients. (1970) (0)
- ORAL MICRONIZED PROGESTERONE AND ALPRAZOLAM TREATMENT FOR PREMENSTRUAL SYMPTOMS (1992) (0)
- Comparisons of the effectiveness of hormonal and CNS medications in PMS treatment (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Karl E. Rickels?
Karl E. Rickels is affiliated with the following schools:
